Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan Kunming Hope of Health Hospital, Kunming, Yunnan